Skip to main content
logo
Green Lifescience Co., Ltd. (KOSDAQ:114450)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,215.00
+10.00 (0.45%)
At close: Sep 18, 2026

Green Lifescience Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
58,57440,34024,86122,36936,50525,338
Revenue Growth
111.03%62.26%11.14%-38.72%44.07%3.16%
Gross Profit
6,0502,4672,980-2,313-1,356-2,270
Operating Income
3,716204.29376.91-4,643-3,958-4,648
Net Income
7,355110.131,562-16,358-3,526-3,136
Earnings Per Share
375.565.7481.18-819.47-176.28-156.79
EPS Growth
--92.93%----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
20,09217,18612,88514,45316,94916,203
Total Debt
5,9806,9925,3724,9336,6247,595
Net Cash (Debt)
14,11110,1947,5139,52010,3248,608
Net Cash Growth
267.37%35.68%-21.08%-7.79%19.93%-1.28%
Net Cash Per Share
720.54531.08390.48476.93516.22430.42

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4,405363.85525.49370.02-4,552611.38
Capital Expenditures
-1,267-859.51-780.62-495.69-1,478-3,444
Free Cash Flow
3,138-495.66-255.13-125.67-6,030-2,832
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
10.33%6.12%11.98%-10.34%-3.72%-8.96%
Operating Margin
6.34%0.51%1.52%-20.76%-10.84%-18.34%
Pretax Margin
12.56%0.27%6.28%-73.13%-7.84%-13.49%
Profit Margin
12.56%0.27%6.28%-73.13%-9.66%-12.38%
FCF Margin
5.36%-1.23%-1.03%-0.56%-16.52%-11.18%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.90514.1620.54---
PS Ratio
0.741.401.291.992.445.98